Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Reeve

Showing results (31-40 of 141) with videos related to

Pageof 15
Sort By:
Journal of Bioethical Inquiry|July 16, 2016
The Ethics of Deprescribing in Older AdultsEmily Reeve, Petra Denig, Sarah N Hilmer, et al.
Therapie|February 19, 2019
Pharmacoepidemiology in older people: Purposes and future directionsMarie-Laure Laroche, Caroline Sirois, Emily Reeve, et al.
Annals of Internal Medicine|March 16, 2026
Incentivizing Deprescribing for Health Care Quality Not QuantityAili V Langford, Emily Reeve, Chung-Wei Christine Lin, et al.
Basic & Clinical Pharmacology & Toxicology|March 28, 2023
The state of deprescribing research: How did we get here?Emily Reeve, Wade Thompson, Cynthia Boyd, et al.
Drugs & Aging|October 8, 2015
Prevalence of Potential and Clinically Relevant Statin-Drug Interactions in Frail and Robust Older InpatientsMichele Thai, Sarah Hilmer, Sallie-Anne Pearson, et al.
The Medical Journal of Australia|October 9, 2014
The benefits and harms of deprescribingEmily Reeve, Sepehr Shakib, Ivanka Hendrix, et al.
British Journal of Clinical Pharmacology|March 26, 2014
Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing processEmily Reeve, Sepehr Shakib, Ivanka Hendrix, et al.
Therapeutic Advances in Drug Safety|November 28, 2018
Clinical practice guidelines for older people with multimorbidity and life-limiting illness: what are the implications for deprescribing?Daniel Okeowo, Alastair Patterson, Cynthia Boyd, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|May 1, 2020
COVID-19 Pandemic: Considerations for Safe Medication Use in Older Adults with Multimorbidity and PolypharmacyNagham J Ailabouni, Sarah N Hilmer, Lisa Kalisch, et al.
The Annals of Pharmacotherapy|June 4, 2016
Health Care Practitioners' Perspectives on Deprescribing Anticholinergic and Sedative Medications in Older AdultsLisa Kouladjian, Danijela Gnjidic, Emily Reeve, et al.
Pageof 15

Showing results (31-40 of 141) with videos related to

Sort By:
Pageof 15
Journal of Bioethical Inquiry|July 16, 2016
The Ethics of Deprescribing in Older AdultsEmily Reeve, Petra Denig, Sarah N Hilmer, et al.
Therapie|February 19, 2019
Pharmacoepidemiology in older people: Purposes and future directionsMarie-Laure Laroche, Caroline Sirois, Emily Reeve, et al.
Annals of Internal Medicine|March 16, 2026
Incentivizing Deprescribing for Health Care Quality Not QuantityAili V Langford, Emily Reeve, Chung-Wei Christine Lin, et al.
Basic & Clinical Pharmacology & Toxicology|March 28, 2023
The state of deprescribing research: How did we get here?Emily Reeve, Wade Thompson, Cynthia Boyd, et al.
Drugs & Aging|October 8, 2015
Prevalence of Potential and Clinically Relevant Statin-Drug Interactions in Frail and Robust Older InpatientsMichele Thai, Sarah Hilmer, Sallie-Anne Pearson, et al.
The Medical Journal of Australia|October 9, 2014
The benefits and harms of deprescribingEmily Reeve, Sepehr Shakib, Ivanka Hendrix, et al.
British Journal of Clinical Pharmacology|March 26, 2014
Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing processEmily Reeve, Sepehr Shakib, Ivanka Hendrix, et al.
Therapeutic Advances in Drug Safety|November 28, 2018
Clinical practice guidelines for older people with multimorbidity and life-limiting illness: what are the implications for deprescribing?Daniel Okeowo, Alastair Patterson, Cynthia Boyd, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|May 1, 2020
COVID-19 Pandemic: Considerations for Safe Medication Use in Older Adults with Multimorbidity and PolypharmacyNagham J Ailabouni, Sarah N Hilmer, Lisa Kalisch, et al.
The Annals of Pharmacotherapy|June 4, 2016
Health Care Practitioners' Perspectives on Deprescribing Anticholinergic and Sedative Medications in Older AdultsLisa Kouladjian, Danijela Gnjidic, Emily Reeve, et al.
Pageof 15